Su Wang

3.1k total citations · 1 hit paper
51 papers, 1.8k citations indexed

About

Su Wang is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Su Wang has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 26 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in Su Wang's work include Hepatitis B Virus Studies (26 papers), Hepatitis C virus research (25 papers) and Liver Disease Diagnosis and Treatment (12 papers). Su Wang is often cited by papers focused on Hepatitis B Virus Studies (26 papers), Hepatitis C virus research (25 papers) and Liver Disease Diagnosis and Treatment (12 papers). Su Wang collaborates with scholars based in United States, China and Australia. Su Wang's co-authors include Steven A. Goldman, Chung S. Yang, Qiming Liang, Jae U. Jung, Jianxiong Zeng, Zhifei Luo, Weiqiang Chen, Berislav V. Zloković, Suan‐Sin Foo and Zhen Zhao and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Su Wang

47 papers receiving 1.8k citations

Hit Papers

Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Sig... 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Signaling in Human Fetal Neural Stem Cells to Inhibit Neurogenesis and Induce Autophagy
    2016 394 citations Qiming Liang, Zhifei Luo et al. Cell stem cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Su Wang United States 18 690 527 349 316 303 51 1.8k
Jun Yao China 29 657 1.0× 1.0k 1.9× 78 0.2× 419 1.3× 158 0.5× 185 3.2k
Anna Pulimood India 27 602 0.9× 378 0.7× 101 0.3× 212 0.7× 425 1.4× 70 2.1k
Mohammad Husain India 26 468 0.7× 865 1.6× 187 0.5× 108 0.3× 691 2.3× 88 2.5k
Klaus‐Peter Zimmer Germany 32 699 1.0× 869 1.6× 122 0.3× 26 0.1× 128 0.4× 123 3.1k
Mohsen Mohammadi Iran 21 179 0.3× 1.1k 2.1× 114 0.3× 52 0.2× 167 0.6× 74 2.1k
Yan Huang China 23 561 0.8× 672 1.3× 100 0.3× 22 0.1× 344 1.1× 123 2.2k
Gabriele Sass United States 32 611 0.9× 1.5k 2.8× 100 0.3× 377 1.2× 437 1.4× 88 3.0k
Makiko Kobayashi United States 26 406 0.6× 610 1.2× 100 0.3× 24 0.1× 178 0.6× 89 2.2k

Countries citing papers authored by Su Wang

Since Specialization
Citations

This map shows the geographic impact of Su Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Wang more than expected).

Fields of papers citing papers by Su Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Wang. The network helps show where Su Wang may publish in the future.

Co-authorship network of co-authors of Su Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Su Wang. A scholar is included among the top collaborators of Su Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Wang. Su Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Chari, Thomas Tu, Philippa C. Matthews, et al.. (2025). Patient and public health perspectives to inform expansion of hepatitis B treatment guidelines. ˜The œLancet. Gastroenterology & hepatology. 10(10). 952–962. 3 indexed citations
2.
Chen, Kai, Yang Yu, Yao Wu, et al.. (2025). PLGA nanoparticles encapsulating TSHR-A and rapamycin enhance the induction of dendritic cell-specific immune tolerance in mice with Graves’ disease. Biomedical Materials. 20(2). 25045–25045. 4 indexed citations
3.
Hunt, Bijou R., Bindu Balani, Chinwe Ogedegbe, et al.. (2024). A US‐Based Multi‐Site Pilot to Screen Hepatitis B Surface Antigen‐Positive Patients for Hepatitis D. Journal of Viral Hepatitis. 32(1). e14043–e14043. 2 indexed citations
4.
Freeland, Catherine, et al.. (2024). Survey of lived experiences and challenges in hepatitis B management and treatment. BMC Public Health. 24(1). 944–944. 3 indexed citations
5.
Wang, Su, et al.. (2024). Association between triglyceride-glucose index and hypertension: a cohort study based on the China Health and Nutrition Survey (2009–2015). BMC Cardiovascular Disorders. 24(1). 168–168. 12 indexed citations
6.
Freeland, Catherine, et al.. (2024). The urgent need to end hepatitis B stigma and discrimination. ˜The œLancet. Gastroenterology & hepatology. 10(2). 105–107. 2 indexed citations
7.
Peters, Marion G., Man‐Fung Yuen, Norah A. Terrault, et al.. (2023). Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes. Clinical Infectious Diseases. 78(4). 983–990. 5 indexed citations
8.
Wang, Su, et al.. (2023). A declaration from people living with hepatitis B: A call for a whole person approach. Journal of Viral Hepatitis. 30(7). 630–630. 2 indexed citations
9.
Maponga, Tongai, Marije Van Schalkwyk, Susan Hugo, et al.. (2023). Barriers that prevent adults living with HBV infection from participating in clinical research: experience from South Africa. Journal of Virus Eradication. 9(1). 100317–100317. 4 indexed citations
10.
Zoulim, Fabien, Adam Zlotnick, Stephanie Buchholz, et al.. (2022). Nomenclature of HBV core protein-targeting antivirals. Nature Reviews Gastroenterology & Hepatology. 19(12). 748–750. 40 indexed citations
11.
Dieterich, Douglas T., Camilla S. Graham, Su Wang, et al.. (2022). It Is Time for a Simplified Approach to Hepatitis B Elimination. SHILAP Revista de lepidopterología. 2(2). 209–218. 17 indexed citations
12.
Wang, Su, et al.. (2021). Hepatitis B Virus Elimination in the U.S.: Time to Dismantle Barriers and Implement Solutions. Current Hepatology Reports. 20(1). 34–42. 6 indexed citations
13.
Wang, Su, et al.. (2021). The impact of COVID-19 on hepatitis services and civil society organisations. ˜The œLancet. Gastroenterology & hepatology. 6(9). 682–684. 5 indexed citations
14.
Liang, Qiming, Zhifei Luo, Jianxiong Zeng, et al.. (2016). Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Signaling in Human Fetal Neural Stem Cells to Inhibit Neurogenesis and Induce Autophagy. Cell stem cell. 19(5). 663–671. 394 indexed citations breakdown →
15.
Liu, Yuanxin, et al.. (2016). C-reactive protein inhibits high-molecular-weight adiponectin expression in 3T3-L1 adipocytes via PI3K/Akt pathway. Biochemical and Biophysical Research Communications. 472(1). 19–25. 4 indexed citations
16.
Liang, Qi, et al.. (2013). Pattern visual evoked potential in varying degrees hyperopic refractive amblyopic children. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Trinh‐Shevrin, Chau, Henry Pollack, Thomas Tsang, et al.. (2011). The Asian American Hepatitis B Program: Building a Coalition to Address Hepatitis B Health Disparities. Progress in community health partnerships. 5(3). 261–271. 20 indexed citations
18.
Windrem, Martha S., Steven J. Schanz, Min Guo, et al.. (2008). Neonatal Chimerization with Human Glial Progenitor Cells Can Both Remyelinate and Rescue the Otherwise Lethally Hypomyelinated Shiverer Mouse. Cell stem cell. 2(6). 553–565. 246 indexed citations
19.
Marín, Yarí E., B. Wall, Su Wang, et al.. (2007). Curcumin downregulates the constitutive activity of NF-κB and induces apoptosis in novel mouse melanoma cells. Melanoma Research. 17(5). 274–283. 92 indexed citations
20.
Li, Ning, Xiaoxin Chen, Jie Liao, et al.. (2002). Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis. 23(8). 1307–1313. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Yao Breakdown of academic impact, for papers by Anna Pulimood Breakdown of academic impact, for papers by Mohammad Husain Breakdown of academic impact, for papers by Klaus‐Peter Zimmer Breakdown of academic impact, for papers by Mohsen Mohammadi Breakdown of academic impact, for papers by Yan Huang Breakdown of academic impact, for papers by Gabriele Sass Breakdown of academic impact, for papers by Makiko Kobayashi
Rankless by CCL
2026